Gilead Sciences, Inc.
GILD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $480 | $5,665 | $4,592 | $6,201 |
| Dep. & Amort. | $2,767 | $2,693 | $2,103 | $2,050 |
| Deferred Tax | -$1,844 | -$962 | -$1,552 | -$116 |
| Stock-Based Comp. | $835 | $766 | $644 | $635 |
| Change in WC | -$880 | -$2,303 | -$1,763 | $489 |
| Other Non-Cash | $9,470 | $2,147 | $5,048 | $2,125 |
| Operating Cash Flow | $10,828 | $8,006 | $9,072 | $11,384 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$523 | -$585 | -$728 | -$579 |
| Net Acquisitions | -$4,840 | -$1,152 | -$1,797 | -$1,584 |
| Inv. Purchases | -$736 | -$2,372 | -$1,942 | -$3,897 |
| Inv. Sales/Matur. | $2,592 | $1,844 | $2,002 | $2,910 |
| Other Inv. Act. | $58 | $0 | -$1 | $19 |
| Investing Cash Flow | -$3,449 | -$2,265 | -$2,466 | -$3,131 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $1,494 | -$270 | -$1,500 | -$4,750 |
| Stock Issued | $422 | $232 | $309 | $169 |
| Stock Repurch. | -$1,150 | -$1,000 | -$1,396 | -$546 |
| Dividends Paid | -$3,918 | -$3,809 | -$3,709 | -$3,605 |
| Other Fin. Act. | -$281 | -$278 | -$173 | -$145 |
| Financing Cash Flow | -$3,433 | -$5,125 | -$6,469 | -$8,877 |
| Forex Effect | -$40 | $57 | -$63 | -$35 |
| Net Chg. in Cash | $3,906 | $673 | $74 | -$659 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,085 | $5,412 | $5,338 | $5,997 |
| End Cash | $9,991 | $6,085 | $5,412 | $5,338 |
| Free Cash Flow | $10,305 | $7,421 | $8,344 | $10,805 |